Just one day after Novartis laid out plans for its long-expected spinoff of its eye unit Alcon, the Swiss pharma giant found itself fending off a rumor that it also intends to wave goodbye to its generics business, Sandoz.
Your email address will not be published. Required fields are marked *
Which of steel, bread, umbrella, robot or cupboard is edible? *
Leave a Comment